Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland.
Mary E WalshTom FaheyFrank MoriartyPublished in: Archives of osteoporosis (2021)
Persistence for osteoporosis medications is suboptimal. Of concern, few patients are switched to other bone-health treatments when denosumab is stopped which could increase fracture risk. Free access to GP services and medications may have resulted in better medication persistence in this cohort. Future research should explore prescribing choices in primary care osteoporosis management and evaluate cost-effectiveness of interventions for improving persistence.
Keyphrases
- primary care
- bone mineral density
- postmenopausal women
- healthcare
- body composition
- end stage renal disease
- newly diagnosed
- mental health
- public health
- chronic kidney disease
- general practice
- prognostic factors
- giant cell
- current status
- emergency department
- adverse drug
- patient reported outcomes
- climate change
- health insurance
- affordable care act